Described herein are pharmaceutical packaging methods which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate prescription drugs, this kind of methods such as a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely low permeability to ox